Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection

Liver fibrosis is a frequent pathological outcome of long-term liver diseases, arising from sustained damage to the liver. Two main types of liver damage can trigger fibrotic progression: hepatocellular injury, often caused by viral infections, alcohol, or metabolic disorders, and cholestatic injury...

Full description

Saved in:
Bibliographic Details
Main Authors: Sharmila Fagoonee, Valeria Menchise, Daniela Delli Castelli, Stefania Bruno
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/13/1025
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849319876978540544
author Sharmila Fagoonee
Valeria Menchise
Daniela Delli Castelli
Stefania Bruno
author_facet Sharmila Fagoonee
Valeria Menchise
Daniela Delli Castelli
Stefania Bruno
author_sort Sharmila Fagoonee
collection DOAJ
description Liver fibrosis is a frequent pathological outcome of long-term liver diseases, arising from sustained damage to the liver. Two main types of liver damage can trigger fibrotic progression: hepatocellular injury, often caused by viral infections, alcohol, or metabolic disorders, and cholestatic injury, associated with impaired bile flow due to autoimmune or congenital conditions. Despite diverse etiologies, liver fibrosis exhibits conserved biological processes, including hepatocyte death, chronic inflammation, disruption of epithelial or endothelial barriers, and excessive deposition of extracellular matrix (ECM) components. These coordinated events reflect the complex interplay among parenchymal damage, immune activation, and fibrogenic signaling pathways. If unresolved, fibrosis may progress to cirrhosis, liver failure, or hepatocellular carcinoma. In the pursuit of non-invasive biomarkers for early detection and monitoring of fibrosis, extracellular vesicles (EVs) have garnered significant attention. Among the diverse cargoes within EVs, microRNAs (miRNAs) have emerged as particularly promising due to their stability, disease-specific expression patterns, and involvement in fibrogenic signaling. This review explores the role of EV-associated miRNAs in liver fibrosis, highlighting key candidates implicated in hepatocellular and cholestatic injury and their clinical potential as diagnostic and prognostic biomarkers, with special focus on MAFLD/MASH, primary sclerosing cholangitis, primary biliary cholangitis, and biliary atresia as representatives.
format Article
id doaj-art-9ea07a605ca74d5eae608b2d195a08a1
institution Kabale University
issn 2073-4409
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-9ea07a605ca74d5eae608b2d195a08a12025-08-20T03:50:17ZengMDPI AGCells2073-44092025-07-011413102510.3390/cells14131025Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis DetectionSharmila Fagoonee0Valeria Menchise1Daniela Delli Castelli2Stefania Bruno3Institute of Biostructure and Bioimaging (CNR), Molecular Biotechnology Center “Guido Tarone”, 10126 Turin, ItalyInstitute of Biostructure and Bioimaging (CNR), Molecular Biotechnology Center “Guido Tarone”, 10126 Turin, ItalyDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center “Guido Tarone”, University of Turin, 10126 Turin, ItalyDepartment of Medical Sciences, University of Torino, 10126 Turin, ItalyLiver fibrosis is a frequent pathological outcome of long-term liver diseases, arising from sustained damage to the liver. Two main types of liver damage can trigger fibrotic progression: hepatocellular injury, often caused by viral infections, alcohol, or metabolic disorders, and cholestatic injury, associated with impaired bile flow due to autoimmune or congenital conditions. Despite diverse etiologies, liver fibrosis exhibits conserved biological processes, including hepatocyte death, chronic inflammation, disruption of epithelial or endothelial barriers, and excessive deposition of extracellular matrix (ECM) components. These coordinated events reflect the complex interplay among parenchymal damage, immune activation, and fibrogenic signaling pathways. If unresolved, fibrosis may progress to cirrhosis, liver failure, or hepatocellular carcinoma. In the pursuit of non-invasive biomarkers for early detection and monitoring of fibrosis, extracellular vesicles (EVs) have garnered significant attention. Among the diverse cargoes within EVs, microRNAs (miRNAs) have emerged as particularly promising due to their stability, disease-specific expression patterns, and involvement in fibrogenic signaling. This review explores the role of EV-associated miRNAs in liver fibrosis, highlighting key candidates implicated in hepatocellular and cholestatic injury and their clinical potential as diagnostic and prognostic biomarkers, with special focus on MAFLD/MASH, primary sclerosing cholangitis, primary biliary cholangitis, and biliary atresia as representatives.https://www.mdpi.com/2073-4409/14/13/1025fibrosischronic liver diseasesextracellular vesiclesmicroRNAsbiomarkers
spellingShingle Sharmila Fagoonee
Valeria Menchise
Daniela Delli Castelli
Stefania Bruno
Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection
Cells
fibrosis
chronic liver diseases
extracellular vesicles
microRNAs
biomarkers
title Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection
title_full Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection
title_fullStr Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection
title_full_unstemmed Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection
title_short Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection
title_sort emerging biomarker potential of extracellular vesicle enclosed micrornas for liver fibrosis detection
topic fibrosis
chronic liver diseases
extracellular vesicles
microRNAs
biomarkers
url https://www.mdpi.com/2073-4409/14/13/1025
work_keys_str_mv AT sharmilafagoonee emergingbiomarkerpotentialofextracellularvesicleenclosedmicrornasforliverfibrosisdetection
AT valeriamenchise emergingbiomarkerpotentialofextracellularvesicleenclosedmicrornasforliverfibrosisdetection
AT danieladellicastelli emergingbiomarkerpotentialofextracellularvesicleenclosedmicrornasforliverfibrosisdetection
AT stefaniabruno emergingbiomarkerpotentialofextracellularvesicleenclosedmicrornasforliverfibrosisdetection